Constitutive pathway activation, through mutation or overexpression of JAK1, JAK3, STAT3, STAT5, and the common gamma chain, have been reported in PTCL and shown to be oncogenic [11, 15, 31–34]. This evidence concerns the gene STAT3 and mature T-cell and NK-cell non-Hodgkin lymphoma.